BIO seeks dynamic, professional candidates with industry expertise and knowledge for our open positions. If you're interested in joining our team, please see the links below to view our current ...

WASHINGTON, D.C. – John F. Crowley, President and CEO of the Biotechnology Innovation Organization (BIO) released the following statement on the potential for 100% tariffs on branded or patented ...

Long-term solutions to combating the opioid crisis will depend upon the development of novel and safer, next-generation therapies to treat both pain and addiction. To get these new innovations to the ...

WASHINGTON, D.C. – John F. Crowley, President and CEO of the Biotechnology Innovation Organization (BIO) released the following statement on Most Favored Nation policies: "For too many years, ...

America leads the world in biotechnology innovation. Yet the U.S. remains the only country where half of every dollar spent on medicine goes to middlemen and supply chain markups - rather than to ...

President Trump announced tariffs of 100% will apply to brand-name pharmaceuticals starting next week, unless a company is building a plant in the U.S. The announcement: “Starting October 1st, 2025, ...

The House passed a one-year reauthorization of the SBIR/STTR programs that BIO supports. Also, BIO hits the road in Texas. (730 words, 3 minutes, 39 seconds) On Sept. 15, the House gave bipartisan ...

Pauline Newman was appointed by President Ronald W. Reagan in 1984. From 1969 to 1984, Judge Newman served as Director, Patent, Trademark and Licensing Department, FMC Corporation, and as house ...